跳至主要内容
临床试验/JPRN-UMIN000028927
JPRN-UMIN000028927已完成未知

Effects of health food products on weight loss in Japanese volunteers whose obesity classification is 1 or 2 as defined by the Japan Society for the Study of Obesity - Effects of health food products on weight loss in Japanese obese volunteers

InCROM Inc.0 个研究点目标入组 90 人开始时间: 2017年9月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
InCROM Inc.
入组人数
90

研究概览

简要总结

A total of 93 subjects started the study diet. Of these 76 completed the study. 78 subjects who had evaluable efficacy data were included in the efficacy analysis set, comprising 13 subjects (M: 5, F: 8) for test diet A, 11 (M: 8, F: 3) for B, 27 (M: 13, F: 14) for C, and 27 subjects (M: 20, F: 7) for test diet D. Percent changes in body weight from baseline to end of test diet and 8 weeks thereafter, and those from end of test diet to 8 weeks thereafter were as follows: -5.8%, -3.8%, 1.7% for diet A, -6.2%, -6.2%, 0.0% for B, -1.5%, -2.5%, -1.0% for C, and -0.0%, -0.5%, -0.4% for diet D. Body weight in diet A was significantly reduced from baseline to end of diet and 8 weeks thereafter, however, it was significantly increased from end of diet to 8 weeks thereafter. Body weight decreases in diets B and C were significant from baseline to end of diet and 8 weeks thereafter, whereas no differences were noted between end of diet and 8 weeks thereafter. Subjects consuming diet D did not show changes in body weight. Changes in BMI were comparable to those in body weight for all diet groups. Decreases in blood pressure, triglycerides, total cholesterol, LDL cholesterol and gamma-GTP were observed for diets A and B. Three (3.2%) out of 93 subjects experienced a total of 3 adverse events related to test diet, all of which were mild in intensity and none of them were clinically significant.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Diabetic patients History of previous or present illness that interferes with ethical conduct of the research as determined by the investigator, e.g., hepatic or renal disorder; cardiovascular, respiratory, endocrine, metabolic, nervous, or psychological disease (except hypertension and dyslipidemia) Known drug or food allergy History of previous or present drug or alcohol dependence

研究者

发起方
InCROM Inc.

相似试验